In 1998, a new class of drugs was approved by the FDA to treat rheumatoid arthritis and related conditions. Enbrel was the first drug in the new class of drugs, known as biologics. Since then, several more injectable and intravenous biologics were approved -- and several more are currently in development. What are biologics? Learn more in Biologics - What Arthritis Patients Should Know.